IBDEI30Y ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48296,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48296,1,3,0)
;;=3^Penis,Ulcer
;;^UTILITY(U,$J,358.3,48296,1,4,0)
;;=4^N48.5
;;^UTILITY(U,$J,358.3,48296,2)
;;=^5015738
;;^UTILITY(U,$J,358.3,48297,0)
;;=N84.9^^185^2420^79
;;^UTILITY(U,$J,358.3,48297,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48297,1,3,0)
;;=3^Polyp,Female Genital Tract,Unspec
;;^UTILITY(U,$J,358.3,48297,1,4,0)
;;=4^N84.9
;;^UTILITY(U,$J,358.3,48297,2)
;;=^5015869
;;^UTILITY(U,$J,358.3,48298,0)
;;=N95.2^^185^2420^80
;;^UTILITY(U,$J,358.3,48298,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48298,1,3,0)
;;=3^Postmenopausal Atrophic Vaginitis
;;^UTILITY(U,$J,358.3,48298,1,4,0)
;;=4^N95.2
;;^UTILITY(U,$J,358.3,48298,2)
;;=^270577
;;^UTILITY(U,$J,358.3,48299,0)
;;=N95.0^^185^2420^81
;;^UTILITY(U,$J,358.3,48299,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48299,1,3,0)
;;=3^Postmenopausal Bleeding
;;^UTILITY(U,$J,358.3,48299,1,4,0)
;;=4^N95.0
;;^UTILITY(U,$J,358.3,48299,2)
;;=^97040
;;^UTILITY(U,$J,358.3,48300,0)
;;=N42.9^^185^2420^84
;;^UTILITY(U,$J,358.3,48300,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48300,1,3,0)
;;=3^Prostate Disorder,Unspec
;;^UTILITY(U,$J,358.3,48300,1,4,0)
;;=4^N42.9
;;^UTILITY(U,$J,358.3,48300,2)
;;=^5015698
;;^UTILITY(U,$J,358.3,48301,0)
;;=N40.1^^185^2420^86
;;^UTILITY(U,$J,358.3,48301,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48301,1,3,0)
;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,48301,1,4,0)
;;=4^N40.1
;;^UTILITY(U,$J,358.3,48301,2)
;;=^5015690
;;^UTILITY(U,$J,358.3,48302,0)
;;=N40.0^^185^2420^87
;;^UTILITY(U,$J,358.3,48302,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48302,1,3,0)
;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,48302,1,4,0)
;;=4^N40.0
;;^UTILITY(U,$J,358.3,48302,2)
;;=^5015689
;;^UTILITY(U,$J,358.3,48303,0)
;;=N41.9^^185^2420^85
;;^UTILITY(U,$J,358.3,48303,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48303,1,3,0)
;;=3^Prostate Inflammatory Disease,Unspec
;;^UTILITY(U,$J,358.3,48303,1,4,0)
;;=4^N41.9
;;^UTILITY(U,$J,358.3,48303,2)
;;=^5015694
;;^UTILITY(U,$J,358.3,48304,0)
;;=C61.^^185^2420^83
;;^UTILITY(U,$J,358.3,48304,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48304,1,3,0)
;;=3^Prostate Cancer
;;^UTILITY(U,$J,358.3,48304,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,48304,2)
;;=^267239
;;^UTILITY(U,$J,358.3,48305,0)
;;=N40.3^^185^2420^88
;;^UTILITY(U,$J,358.3,48305,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48305,1,3,0)
;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,48305,1,4,0)
;;=4^N40.3
;;^UTILITY(U,$J,358.3,48305,2)
;;=^5015692
;;^UTILITY(U,$J,358.3,48306,0)
;;=N40.2^^185^2420^89
;;^UTILITY(U,$J,358.3,48306,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48306,1,3,0)
;;=3^Prostate,Nodular w/o Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,48306,1,4,0)
;;=4^N40.2
;;^UTILITY(U,$J,358.3,48306,2)
;;=^5015691
;;^UTILITY(U,$J,358.3,48307,0)
;;=Z87.430^^185^2420^76
;;^UTILITY(U,$J,358.3,48307,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48307,1,3,0)
;;=3^Personal Hx of Prostatic Dysplasia
;;^UTILITY(U,$J,358.3,48307,1,4,0)
;;=4^Z87.430
;;^UTILITY(U,$J,358.3,48307,2)
;;=^5063493
;;^UTILITY(U,$J,358.3,48308,0)
;;=N41.2^^185^2420^1
;;^UTILITY(U,$J,358.3,48308,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI30Y 3748 printed Sep 23, 2025@20:15:41 Page 2
IBDEI30Y ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48296,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,48296,1,3,0)
+4 ;;=3^Penis,Ulcer
+5 ;;^UTILITY(U,$J,358.3,48296,1,4,0)
+6 ;;=4^N48.5
+7 ;;^UTILITY(U,$J,358.3,48296,2)
+8 ;;=^5015738
+9 ;;^UTILITY(U,$J,358.3,48297,0)
+10 ;;=N84.9^^185^2420^79
+11 ;;^UTILITY(U,$J,358.3,48297,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,48297,1,3,0)
+14 ;;=3^Polyp,Female Genital Tract,Unspec
+15 ;;^UTILITY(U,$J,358.3,48297,1,4,0)
+16 ;;=4^N84.9
+17 ;;^UTILITY(U,$J,358.3,48297,2)
+18 ;;=^5015869
+19 ;;^UTILITY(U,$J,358.3,48298,0)
+20 ;;=N95.2^^185^2420^80
+21 ;;^UTILITY(U,$J,358.3,48298,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,48298,1,3,0)
+24 ;;=3^Postmenopausal Atrophic Vaginitis
+25 ;;^UTILITY(U,$J,358.3,48298,1,4,0)
+26 ;;=4^N95.2
+27 ;;^UTILITY(U,$J,358.3,48298,2)
+28 ;;=^270577
+29 ;;^UTILITY(U,$J,358.3,48299,0)
+30 ;;=N95.0^^185^2420^81
+31 ;;^UTILITY(U,$J,358.3,48299,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,48299,1,3,0)
+34 ;;=3^Postmenopausal Bleeding
+35 ;;^UTILITY(U,$J,358.3,48299,1,4,0)
+36 ;;=4^N95.0
+37 ;;^UTILITY(U,$J,358.3,48299,2)
+38 ;;=^97040
+39 ;;^UTILITY(U,$J,358.3,48300,0)
+40 ;;=N42.9^^185^2420^84
+41 ;;^UTILITY(U,$J,358.3,48300,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,48300,1,3,0)
+44 ;;=3^Prostate Disorder,Unspec
+45 ;;^UTILITY(U,$J,358.3,48300,1,4,0)
+46 ;;=4^N42.9
+47 ;;^UTILITY(U,$J,358.3,48300,2)
+48 ;;=^5015698
+49 ;;^UTILITY(U,$J,358.3,48301,0)
+50 ;;=N40.1^^185^2420^86
+51 ;;^UTILITY(U,$J,358.3,48301,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,48301,1,3,0)
+54 ;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
+55 ;;^UTILITY(U,$J,358.3,48301,1,4,0)
+56 ;;=4^N40.1
+57 ;;^UTILITY(U,$J,358.3,48301,2)
+58 ;;=^5015690
+59 ;;^UTILITY(U,$J,358.3,48302,0)
+60 ;;=N40.0^^185^2420^87
+61 ;;^UTILITY(U,$J,358.3,48302,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,48302,1,3,0)
+64 ;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
+65 ;;^UTILITY(U,$J,358.3,48302,1,4,0)
+66 ;;=4^N40.0
+67 ;;^UTILITY(U,$J,358.3,48302,2)
+68 ;;=^5015689
+69 ;;^UTILITY(U,$J,358.3,48303,0)
+70 ;;=N41.9^^185^2420^85
+71 ;;^UTILITY(U,$J,358.3,48303,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,48303,1,3,0)
+74 ;;=3^Prostate Inflammatory Disease,Unspec
+75 ;;^UTILITY(U,$J,358.3,48303,1,4,0)
+76 ;;=4^N41.9
+77 ;;^UTILITY(U,$J,358.3,48303,2)
+78 ;;=^5015694
+79 ;;^UTILITY(U,$J,358.3,48304,0)
+80 ;;=C61.^^185^2420^83
+81 ;;^UTILITY(U,$J,358.3,48304,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,48304,1,3,0)
+84 ;;=3^Prostate Cancer
+85 ;;^UTILITY(U,$J,358.3,48304,1,4,0)
+86 ;;=4^C61.
+87 ;;^UTILITY(U,$J,358.3,48304,2)
+88 ;;=^267239
+89 ;;^UTILITY(U,$J,358.3,48305,0)
+90 ;;=N40.3^^185^2420^88
+91 ;;^UTILITY(U,$J,358.3,48305,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,48305,1,3,0)
+94 ;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
+95 ;;^UTILITY(U,$J,358.3,48305,1,4,0)
+96 ;;=4^N40.3
+97 ;;^UTILITY(U,$J,358.3,48305,2)
+98 ;;=^5015692
+99 ;;^UTILITY(U,$J,358.3,48306,0)
+100 ;;=N40.2^^185^2420^89
+101 ;;^UTILITY(U,$J,358.3,48306,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,48306,1,3,0)
+104 ;;=3^Prostate,Nodular w/o Lower Urinary Tract Symptoms
+105 ;;^UTILITY(U,$J,358.3,48306,1,4,0)
+106 ;;=4^N40.2
+107 ;;^UTILITY(U,$J,358.3,48306,2)
+108 ;;=^5015691
+109 ;;^UTILITY(U,$J,358.3,48307,0)
+110 ;;=Z87.430^^185^2420^76
+111 ;;^UTILITY(U,$J,358.3,48307,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,48307,1,3,0)
+114 ;;=3^Personal Hx of Prostatic Dysplasia
+115 ;;^UTILITY(U,$J,358.3,48307,1,4,0)
+116 ;;=4^Z87.430
+117 ;;^UTILITY(U,$J,358.3,48307,2)
+118 ;;=^5063493
+119 ;;^UTILITY(U,$J,358.3,48308,0)
+120 ;;=N41.2^^185^2420^1
+121 ;;^UTILITY(U,$J,358.3,48308,1,0)
+122 ;;=^358.31IA^4^2
